Literature DB >> 11723014

Time to treatment influences the impact of ST-segment resolution on one-year prognosis: insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trial.

Y Fu1, S Goodman, W C Chang, F Van De Werf, C B Granger, P W Armstrong.   

Abstract

BACKGROUND: Early ST resolution after reperfusion is a prognostic indicator in acute myocardial infarction. Little information exists regarding the prognostic utility of ST resolution beyond 4 hours after fibrinolysis. Furthermore, the relation between time to treatment, ST resolution at 24 to 36 hours, and 1-year outcome has not been well studied. Accordingly, we undertook a prospective ECG substudy in the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) trial to examine this. METHODS AND
RESULTS: Patients (n=13 100) were stratified into 3 ST-resolution categories, based on baseline and 24- to 36-hour ECGs: complete resolution (>/=70%) in 6698 (51.1%) patients, partial resolution (30% to 70%) in 4610 (35.2%) patients, and no resolution (<30%) in 1792 (13.7%) patients; 1-year mortality rate was 5.1%, 8.0%, and 9.7%, respectively (P<0.001). Among patients treated <2 hours after symptom onset, 55.6% had complete ST resolution, whereas 52.1% and 43% of patients treated between 2 to 4 hours and 4 to 6 hours, respectively, had complete ST resolution (P<0.001). Within each category of ST resolution, patients treated <2 hours had lower 1-year mortality rates as compared with patients treated between 2 to 4 hours or >4 hours (3.8% versus 5.2% and 6.6%, P=0.002 in complete ST resolution; 5.7% versus 8.4% and 9.9%, P=0.001 in partial ST resolution; 7.1% versus 8.7% and 13%, P=0.006 in no resolution). The extent of ST resolution was closely and inversely correlated with 1-year mortality rates (r=-0.963, P<0.001).
CONCLUSIONS: ST resolution at 24 to 36 hours after fibrinolysis is influenced by time to treatment and inversely related to 1-year mortality rates. Time to treatment further differentiates between high- and low-risk patients and further highlights the importance of reducing time delay to initiation of fibrinolysis in acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11723014     DOI: 10.1161/hc4701.099731

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  [Prediction of outcome in ST elevation myocardial infarction by the extent of ST segment deviation recovery. Which method is best?].

Authors:  K Schröder; U Zeymer; W Wegschneider; R Schröder
Journal:  Z Kardiol       Date:  2004-08

Review 2.  Therapeutic Approach to Hypertension Urgencies and Emergencies During Acute Coronary Syndrome.

Authors:  Giuliano Tocci; Ilaria Figliuzzi; Vivianne Presta; Francesca Miceli; Barbara Citoni; Roberta Coluccia; Maria Beatrice Musumeci; Andrea Ferrucci; Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-07-31

3.  Abortion of acute ST segment elevation myocardial infarction after reperfusion: incidence, patients' characteristics, and prognosis.

Authors:  E J P Lamfers; T E H Hooghoudt; D P Hertzberger; A Schut; P W J Stolwijk; F W A Verheugt
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

4.  Evaluating the views of paramedics, cardiologists, emergency department physicians and nurses on advanced prehospital management of acute ST elevation myocardial infarction.

Authors:  Naheed A Rajabali; Ross T Tsuyuki; Sunil Sookram; Scot H Simpson; Robert C Welsh
Journal:  Can J Cardiol       Date:  2009-09       Impact factor: 5.223

5.  The impact of personality factors on delay in seeking treatment of acute myocardial infarction.

Authors:  Mona Schlyter; Lena André-Petersson; Gunnar Engström; Patrik Tydén; Margareta Östman
Journal:  BMC Cardiovasc Disord       Date:  2011-05-19       Impact factor: 2.298

6.  Reduction in Door-to-Needle Time after Transfer of Thrombolysis Site from CCU to Emergency Department.

Authors:  Osama Mohammed; Firjith C Paramba; Naushad V Aboobaker; Riyadh A Mohammed; Nishan K Purayil; Haitham M Jassim; Mohammad K Shariff; Saud M Aslam; Farook F Muhsen; Khalid H Al Noor; Hani H Al Kilani
Journal:  Emerg Med Int       Date:  2013-09-24       Impact factor: 1.112

7.  Components and determinants of therapeutic delay in patients with acute ST-elevation myocardial infarction: A tertiary care hospital-based study.

Authors:  Jahangir Rashid Beig; Nisar A Tramboo; Kuldeep Kumar; Irfan Yaqoob; Imran Hafeez; Fayaz A Rather; Tariq R Shah; Hilal A Rather
Journal:  J Saudi Heart Assoc       Date:  2016-06-16

8.  Glycemic variability is associated with myocardial damage in nondiabetic patients with ST-elevation myocardial infarction.

Authors:  Satoshi Oka; Juntaro Deyama; Ken Umetani; Tomoko Harama; Takuya Shimizu; Aritaka Makino; Keita Sano; Masahiko Nakamura
Journal:  Cardiovasc Endocrinol Metab       Date:  2018-05-16

Review 9.  Mitochondrial Quality Control: Role in Cardiac Models of Lethal Ischemia-Reperfusion Injury.

Authors:  Andrew R Kulek; Anthony Anzell; Joseph M Wider; Thomas H Sanderson; Karin Przyklenk
Journal:  Cells       Date:  2020-01-15       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.